Recreational marijuana sales in Canada are only one aspect of a growing global industry, with companies such as Canopy Growth Corporation (TSX:WEED; NYSE:CGC) seeking to grow beyond their home borders and break into the medical sector on an international scale.
To further that goal, Canopy just brought on Dr. Danial Schecter to serve as the Director Of Global Medical Services. Dr. Schecter was recruited from his previous role as director of the referral-only Canabo Medical Clinics chain.
In this new position, Dr. Schechter will be responsible for growing out the company’s roster of partnered clinics both in Canada and abroad, as well as educating medical staff while developing training materials.
Increased access to education and training has been an ongoing focus for the industry with legalization arriving in Canada last October and expected to occur in other nations in the coming years.
In late 2018, Canopy’s subsidiary Tweed launched the Hi. Society program to educate retail staff across the country. Other companies have also sought to increase training globally, with Aphria Inc. (TSX: APHA; NYSE: APHA) subsidiary Colcanna SAS signing a deal to develop cannabis-focused medical curriculum for students in Colombia.
Commenting on his new position, Dr. Schecter issued this statement about joining Canopy’s upper management:
Aside from bringing on the new Director Of Global Medical Services, Canopy is also seeking to make a mark on the initial launch of retail cannabis stores in Ontario later this year.
While the company wasn’t selected in the first batch of 25 retailers chosen by random lottery, Canopy will still be involved in one store’s opening via a strategic partnership.
Yesterday, Canopy announced the new partnership with Alimentation Couche-Tard Inc. (TSX: ATD.A) to provide a trademark license agreement with one of the lottery winners.
While that lottery winner will retain control of the store, it will be branded with Canopy’s Tweed subsidiary and is expected to open at 1025 Wellington Road in London, Ontario this coming April.
A full rundown of Canopy’s Q2 2019 earnings was also released earlier this week and can be found here.
The opinions provided in this article are those of the author and do not constitute investment advice. Readers should assume that the author and/or employees of Grizzle hold positions in the company or companies mentioned in the article. For more information, please see our Content Disclaimer.